Both Semaglutide and Mounjaro represent new strategies to addressing type 2 diabetes, and increasingly, obesity. It is a dual agonist that works on multiple hormones involved in blood sugar control: GLP-1 and a similar https://letusbookmark.com/story24218410/comprehending-tirzepatide-mounjaro-a-comprehensive-guide